ELI LILLY & Co is 792.2x more valuable than ATAI Life Sciences N.V. by market capitalization ($1.093 T vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATAI | LLY |
|---|---|---|
| Market cap | $1.38 B | $1.093 T |
| US-listed rank | #2408 | #11 |
| Revenue (latest FY) | $308.00K | $65.18B |
| Net income (latest FY) | -$149.27M | $20.64B |
| Net margin | -48464.0% | 31.7% |
| P/E (trailing FY) | - | 53.0 |
| SEC filings | 320 | 989 |
ELI LILLY & Co is 792.2x more valuable than ATAI Life Sciences N.V. by market capitalization ($1.093 T vs $1.38 B).
In their latest fiscal years, ATAI Life Sciences N.V. reported $308.00K in revenue while ELI LILLY & Co reported $65.18B.
Full pages: ATAI Life Sciences N.V. and ELI LILLY & Co, or browse the full rankings.